missing translation for 'onlineSavingsMsg'
Learn More

CDC25B Antibody (3D6), Novus Biologicals™

Rabbit Monoclonal Antibody

343.00 € - 533.00 €

Specifications

Antigen CDC25B
Clone 3D6
Dilution ELISA
Applications ELISA
Classification Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
30043828
View Documents
Novus Biologicals
NBP3-26672-50ul
50 μL
343.00 €
50µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
30043840
View Documents
Novus Biologicals
NBP3-26672-100ul
100 μL
533.00 €
100µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

CDC25B Monoclonal antibody specifically detects CDC25B in Human samples. It is validated for ELISA
Specifications

Specifications

CDC25B
ELISA
Monoclonal
Purified
RUO
Human
CDC25HU2, cell division cycle 25 homolog B (S. cerevisiae), cell division cycle 25 homolog B (S. pombe), cell division cycle 25B, Dual specificity phosphatase Cdc25B, EC 3.1.3.48, M-phase inducer phosphatase 2
A synthesized peptide derived from Human CDC25B [UniProt P30305]
Primary
Store at -20 to -70C. Avoid freeze-thaw cycles.
3D6
ELISA
Unconjugated
Rabbit
Cancer, Cell Cycle and Replication, Phospho Specific
PBS, pH 7.4, 150mM NaCl and 50% glycerol
994
IgG
Affinity purified
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.